Mesenchymal Stem Cell-Derived Exosomal Noncoding RNAs as Alternative Treatments for Myocardial Ischemia-Reperfusion Injury: Current Status and Future Perspectives

Ischemic cardiomyopathy is treated mainly with thrombolytic drugs, percutaneous coronary intervention, and coronary artery bypass grafting to recanalize blocked vessels. Myocardial ischemia-reperfusion injury (MIRI) is an unavoidable complication of obstructive revascularization. Compared with those...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cardiovascular translational research 2023-10, Vol.16 (5), p.1085-1098
Hauptverfasser:	Chang, Chen, Cai, Ru-Ping, Su, Ying-Man, Wu, Qiang, Su, Qiang
Format:	Artikel
Sprache:	eng
Schlagworte:	Apoptosis Biomedical Engineering and Bioengineering Biomedicine Cardiology Exosomes - metabolism Human Genetics Humans Medicine Medicine & Public Health Mesenchymal Stem Cells - metabolism MicroRNAs - genetics MicroRNAs - metabolism Myocardial Reperfusion Injury - drug therapy Myocardial Reperfusion Injury - genetics Myocardial Reperfusion Injury - prevention & control Myocytes, Cardiac - metabolism Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!